Literature DB >> 11506989

Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding.

T Doi1, M Liu, R J Seeley, S C Woods, P Tso.   

Abstract

We determined apolipoprotein AIV (apo AIV) content in intestinal epithelial cells using immunohistochemistry when leptin was administered intravenously. Most of the apo AIV immunoreactivity in the untreated intestine was located in the villous cells as opposed to the crypt cells. Regional distribution of apo AIV immunostaining revealed low apo AIV content in the duodenum and high content in the jejunum that gradually decreases caudally toward the ileum. Intraduodenal infusion of lipid (4 h) significantly increased apo AIV immunoreactivity in the jejunum and ileum. Simultaneous intravenous leptin infusion plus duodenal lipid infusion markedly suppressed apo AIV immunoreactivity. Duodenal lipid infusion increased plasma apo AIV significantly (measured by ELISA), whereas simultaneous leptin infusion attenuated the increase. These findings suggest that leptin may regulate circulating apo AIV by suppressing apo AIV synthesis in the small intestine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506989     DOI: 10.1152/ajpregu.2001.281.3.R753

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  18 in total

1.  Gut triglyceride production.

Authors:  Xiaoyue Pan; M Mahmood Hussain
Journal:  Biochim Biophys Acta       Date:  2011-10-02

2.  Estradiol increases the anorectic effect of central apolipoprotein A-IV.

Authors:  Ling Shen; David Q-H Wang; Chun-Min Lo; Patrick Tso; W Sean Davidson; Stephen C Woods; Min Liu
Journal:  Endocrinology       Date:  2010-05-19       Impact factor: 4.736

3.  Circulating Apolipoprotein A-IV presurgical levels are associated with improvement in insulin sensitivity after Roux-en-Y gastric bypass surgery.

Authors:  Raghavendra Rao; Alexander Roche; Gerardo Febres; Marc Bessler; Patrick Tso; Judith Korner
Journal:  Surg Obes Relat Dis       Date:  2016-10-26       Impact factor: 4.734

4.  Regularization Methods for High-Dimensional Instrumental Variables Regression With an Application to Genetical Genomics.

Authors:  Wei Lin; Rui Feng; Hongzhe Li
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

5.  Effect of peripheral administration of cholecystokinin on food intake in apolipoprotein AIV knockout mice.

Authors:  Go Yoshimichi; Chunmin C Lo; Kellie L K Tamashiro; Liyun Ma; Dana M Lee; Denovan P Begg; Min Liu; Randall R Sakai; Stephen C Woods; Hironobu Yoshimatsu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

Review 6.  ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Authors:  Alison B Kohan; Fei Wang; Chun-Min Lo; Min Liu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

7.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

Review 8.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

9.  Characterization of apolipoprotein A-IV in brain areas involved in energy homeostasis.

Authors:  Ling Shen; Kevin J Pearson; Ye Xiong; Chun-Min Lo; Patrick Tso; Stephen C Woods; W Sean Davidson; Min Liu
Journal:  Physiol Behav       Date:  2008-06-05

10.  Leptin and the obesity receptor (OB-R) in the small intestine and colon: a colocalization study.

Authors:  Gert H Hansen; Lise-Lotte Niels-Christiansen; E Michael Danielsen
Journal:  J Histochem Cytochem       Date:  2008-04-14       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.